Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by Lagrenouilleon Aug 05, 2020 5:48pm

143 Views

Post# 31369435

RE:RE:RE:RE:SONA should give an update

Cottrader,

The NR message would therefore be that the trials are performed as predicted and SONA is waiting for the final written report for revision prior to submission to FDA!
That type of update would not harm anyone just simple factual update.
We are expecting the samething, my suggestion to inform investors is the only difference.
They called the shot on July 2nd.
GLTA

Bullboard Posts

Canada invests $3.9 million in Malaysian cybersecurity